IMAX Corporation

Report azionario NYSE:IMAX

Capitalizzazione di mercato: US$2.9b

IMAX Crescita futura

Criteri Future verificati 3/6

IMAX prevede che gli utili e i ricavi cresceranno rispettivamente di 21.6% e 6.3% all'anno. Si prevede che l'EPS crescerà di 27.5% all'anno. Si prevede che il ritorno sul capitale proprio sarà di 16.9% in 3 anni.

Informazioni chiave

21.6%

Tasso di crescita degli utili

27.51%

Tasso di crescita dell'EPS

Entertainment crescita degli utili24.0%
Tasso di crescita dei ricavi6.3%
Rendimento futuro del capitale proprio16.86%
Copertura analitica

Good

Ultimo aggiornamento09 Sep 2026

Aggiornamenti recenti sulla crescita futura

Recent updates

Aggiornamento narrativa • Sep 07

IMAX: Premium Formats And Network Expansion Will Shape Balanced Odyssey-Led Outlook

IMAX's analyst fair value estimate has shifted from $52.73 to $55.65 as analysts lift price targets into the $60 to $65 range, citing stronger box office contributions from The Odyssey, higher Q3 revenue expectations, and ongoing network growth. Analyst Commentary Recent commentary on IMAX is skewed toward optimism, with many bullish analysts lifting price targets into the $60 to $65 range, while a smaller group urges more caution.
Aggiornamento narrativa • Aug 24

IMAX: Premium Formats And Network Expansion Will Underpin Balanced Future Outlook

Analysts have nudged their fair value estimate for IMAX higher, with the updated target of $52.73 from $50.27. This reflects recent price target increases tied to stronger Q3 box office expectations around "The Odyssey," ongoing momentum in premium formats, and anticipated margin and cash flow benefits from network expansion.
Aggiornamento narrativa • Aug 07

IMAX: Premium Formats And Sale Optionality Will Shape Balanced Future Outlook

Analysts have raised the IMAX fair value estimate from about $46.82 to roughly $50.27, citing higher Street price targets clustered around $50 to $54. They highlight stronger Q2 results, growing consumer preference for IMAX screenings, and continued network expansion supported by titles like The Odyssey.
Aggiornamento narrativa • Jul 24

IMAX: Filmed For Large Format Slate And Potential Sale Will Support Upside

Analysts have raised the updated fair value estimate for IMAX from $55.99 to $59.72, citing higher Street price targets supported by a Q2 earnings beat, strong performance from "The Odyssey," increasing demand for filmed-for-IMAX content, and ongoing global system installations. Analyst Commentary Bullish analysts covering IMAX are largely framing the recent Q2 earnings beat and the success of "The Odyssey" as key supports for higher valuation ranges, with a series of price target increases reflecting confidence in both execution and growth initiatives.
Seeking Alpha • Jul 24

IMAX Corporation: Box Office Expansion Drives The Investment

Summary IMAX Corporation reported solid Q2 results, driven by higher system installations in theaters. The short-term forward outlook is driven by a favorable film slate, notably including The Odyssey, filmed fully on IMAX 70mm film cameras. IMAX should continue to gain box office market share in upcoming years, driven by filmmaker interest and theater network expansion. After a strong stock rally, IMAX stock's base scenario growth potential is already priced in. I estimate a fair value of $43.9. Read the full article on Seeking Alpha
Articolo di analisi • Jun 18

IMAX (IMAX) Stock Could Be 5.3% Undervalued After Disclosure Day Opening Weekend

IMAX (IMAX) stock moved after Universal’s Disclosure Day delivered a robust opening weekend, with IMAX premium screens capturing nearly 15% of the film’s US$93.9 million global box office. See our latest analysis for IMAX. Beyond this weekend’s box office boost, IMAX’s recent share price momentum has been building, with a 30 day share price return of 33.97% and a 1 year total shareholder return of 51.82% reflecting how investors are reassessing both growth potential and risk. If this kind of...
Aggiornamento narrativa • Jun 15

IMAX: Film Slate Management And Potential Sale Will Support Future Upside

The analyst price target for IMAX has increased from $47.00 to about $56.00, as analysts point to stronger margin potential, active film slate management and renewed interest following reports that the company is exploring a possible sale. Analyst Commentary Recent research has centered on how the current film slate, margin potential and potential corporate activity could affect the stock's valuation.
Aggiornamento narrativa • Jun 01

IMAX: Premium Formats And Potential Sale Interest Will Drive Future Upside

Analysts have nudged their implied fair value estimate for IMAX higher from about $45.27 to $46.82, citing expectations for stronger revenue growth, higher forecast margins, and recent Street research that highlights potential corporate interest in the company. Analyst Commentary Recent Street research around IMAX reflects an active debate on valuation, execution, and potential corporate interest in the company.
Aggiornamento narrativa • May 02

IMAX: Global Premium Footprint Expansion Will Shape Future Earnings Power

The analyst price target for IMAX edges higher to about $41.09 from $41.00 as analysts incorporate mixed target moves across firms, modest adjustments to revenue growth and margin assumptions, and slightly higher future P/E expectations. Analyst Commentary Recent Street research on IMAX presents a mixed picture, with several firms lifting price targets while a smaller group trims expectations and highlights areas of risk.
Aggiornamento narrativa • Apr 18

IMAX: Premium Theatrical Formats And Strong Box Office Will Drive Future Upside

The IMAX analyst price target edges higher to about $45.27 from $45.00, as analysts factor in recent target raises tied to strong Q4 results, higher box office activity, robust system installs, and expectations for continued importance within the global theatrical ecosystem. Analyst Commentary Recent Street research on IMAX clusters around higher price targets and generally positive reactions to the latest quarterly results, box office trends, and system installation activity.
Aggiornamento narrativa • Apr 04

IMAX: Future Earnings Base And Global Footprint Frame Balanced Opportunity And Risk

Narrative Update: IMAX Analyst Price Target Shift The analyst price target for IMAX has moved to $41.00. Analysts cite record share gains, accelerating international expansion, strong Q4 and full-year revenue and margins, and continued outperformance versus consensus as key factors influencing their updated views.
Aggiornamento narrativa • Mar 21

IMAX: Record Box Office And Premium Format Position Will Support Future Upside

The analyst price target for IMAX is raised by about $1 to $45.00, as analysts factor in higher margin expectations, a lower assumed future P/E multiple, and recent research citing strong quarterly results, record box office driven revenue, and a stronger position in the global theatrical ecosystem. Analyst Commentary Recent research updates show a cluster of target price increases for IMAX, with analysts reacting to reported results, box office trends, and the company’s role in premium theatrical formats.
Aggiornamento narrativa • Mar 06

IMAX: Future Earnings Base And International Footprint Suggest Balanced Opportunity And Risk

The Analyst Price Target for IMAX has increased from $22.04 to $41.00. This reflects analysts' views that recent record revenue, strong margins, higher box office activity and an expanding international footprint support a higher assumed profit margin and P/E multiple in updated models.
Aggiornamento narrativa • Feb 20

IMAX: Live Sports And Content Partnerships Will Support Future Upside

Analysts have maintained their $47.00 price target on IMAX, citing updated assumptions around discount rate, revenue growth, profit margin, and a higher future P/E multiple. They also highlight broader sector risks such as high development costs, dependence on single assets, and limited near term catalysts in comparable coverage.
Aggiornamento narrativa • Feb 05

IMAX: Future Slate And Execution Will Support Expanded Premium Format Opportunities

Analysts have inched their price target for IMAX higher to approximately US$44.09 from about US$43.73, reflecting updated assumptions around revenue growth, profit margins and future P/E levels. Analyst Commentary Analysts have updated their IMAX models around revenue, margins and future P/E levels, which feeds directly into the small lift in the price target to about US$44.09.
Aggiornamento narrativa • Jan 22

IMAX: Future Slate And Profit Execution Will Support Measured Upside Potential

Analysts have lifted their IMAX fair value estimate from about US$38.81 to roughly US$43.73 per share, citing updated assumptions for revenue growth, profit margins and a lower future P/E that together support a higher price target. Analyst Commentary Analysts reviewing IMAX after the updated fair value estimate are split between what could support the higher valuation and what might limit upside if execution falls short.
Aggiornamento narrativa • Jan 08

IMAX: Premium Screens And Local Language Hits Will Support Future Upside

Analysts have raised their price target on IMAX to $40 from $36, citing record Q3 global box office results, an increasing market share, strong local language titles, and faster-than-expected network expansion in markets with above-average revenue per screen. Analyst Commentary Bullish analysts point to IMAX's recent record Q3 global box office results and its second highest quarterly gross as key supports for their updated views, highlighting what they see as solid execution across the business.
Aggiornamento narrativa • Dec 21

IMAX: Expanding Premium Network Will Drive Stronger Box Office Performance

Analysts have lifted their price target on IMAX to approximately $47 from about $38, citing accelerating network expansion into higher revenue markets, record and resilient box office performance, and an expectation for stronger, more profitable growth that, in their view, supports a lower forward earnings multiple versus historical levels. Analyst Commentary Bullish analysts have recently highlighted IMAX as one of the stronger execution stories in the theatrical ecosystem, pointing to a mix of box office outperformance, premium market exposure, and disciplined capital deployment as key supports for higher valuation.
Aggiornamento narrativa • Dec 07

IMAX: Future Slate And Premium Screen Expansion Will Drive Measured Performance

We raise our IMAX price target to approximately $39 from about $37, as analysts highlight record Q3 box office performance, accelerating high value screen expansion, and a robust Q4 film slate that together support modestly stronger growth and valuation assumptions. Analyst Commentary Recent Street commentary on IMAX has tilted clearly positive, with multiple firms raising price targets in response to stronger than expected operating trends and an improving growth outlook.
Aggiornamento narrativa • Nov 22

IMAX: Future Box Office Releases And Network Expansion Will Shape Performance

IMAX's analyst price target has increased significantly, rising from $36 to $37 per share to $40 to $42 per share, as analysts cite strong quarterly box office results, ongoing network expansion, and promising upcoming film releases as key drivers of growth. Analyst Commentary Recent updates from street research provide insights into the positive momentum behind IMAX's upgraded price targets, as well as areas of continued scrutiny among analysts.
Aggiornamento narrativa • Nov 01

IMAX: Accelerating Network Expansion Will Drive Global Box Office Performance

The analyst consensus price target for IMAX has increased from approximately $36.45 to $37.18. Analysts highlight strong box office performance and accelerating network expansion as key drivers for the upward revision.
Aggiornamento narrativa • Oct 18

North America And Japan Installations Will Strengthen Premium Entertainment

Analysts have raised their price target for IMAX from approximately $34.36 to $36.45. They cite stronger box office performance, accelerating network expansion, and improved margins as key factors supporting the higher valuation.
Aggiornamento narrativa • Oct 04

North America And Japan Installations Will Strengthen Premium Entertainment

IMAX's analyst price target has been raised from $31 to $38, reflecting higher expected margins and valuation multiples according to analysts. Analyst Commentary Analyst sentiment toward IMAX has recently shifted, leading to an upward revision of the company's price target.
Articolo di analisi • Sep 09

Earnings Tell The Story For IMAX Corporation (NYSE:IMAX) As Its Stock Soars 25%

IMAX Corporation ( NYSE:IMAX ) shares have had a really impressive month, gaining 25% after a shaky period beforehand...
Articolo di analisi • Aug 04

Is Now An Opportune Moment To Examine IMAX Corporation (NYSE:IMAX)?

IMAX Corporation ( NYSE:IMAX ), is not the largest company out there, but it received a lot of attention from a...
Articolo di analisi • Jun 13

An Intrinsic Calculation For IMAX Corporation (NYSE:IMAX) Suggests It's 32% Undervalued

Key Insights IMAX's estimated fair value is US$42.15 based on 2 Stage Free Cash Flow to Equity Current share price of...
Articolo di analisi • May 17

Market Participants Recognise IMAX Corporation's (NYSE:IMAX) Earnings Pushing Shares 25% Higher

IMAX Corporation ( NYSE:IMAX ) shares have had a really impressive month, gaining 25% after a shaky period beforehand...
Articolo di analisi • May 02

IMAX's (NYSE:IMAX) Soft Earnings Are Actually Better Than They Appear

Shareholders appeared unconcerned with IMAX Corporation's ( NYSE:IMAX ) lackluster earnings report last week. We think...
Articolo di analisi • Apr 19

Should You Investigate IMAX Corporation (NYSE:IMAX) At US$22.45?

While IMAX Corporation ( NYSE:IMAX ) might not have the largest market cap around , it saw significant share price...
Articolo di analisi • Apr 04

Here's What's Concerning About IMAX's (NYSE:IMAX) Returns On Capital

When it comes to investing, there are some useful financial metrics that can warn us when a business is potentially in...
Articolo di analisi • Mar 15

We Think IMAX (NYSE:IMAX) Can Stay On Top Of Its Debt

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it might be obvious that you need to...
Seeking Alpha • Mar 09

IMAX Corporation: Unlocking Asymmetric Gains In Premium Cinema

Summary IMAX remains the leading choice for premium cinema experiences, generating outsized box office returns despite a small footprint of 1% of total screens. The company’s success in China is encouraging, but future box office results may be dampened due to a lack of new local content. IMAX’s global expansion in local language partnerships could face higher costs and challenges adapting to diverse filmmaking workflows. While financially recovered from the pandemic, IMAX’s growth trajectory appears plateaued, with flat revenue and cash flow projections. Given the overvaluation of IMAX stock, investors should hold and wait for a significant price retracement before considering entry. Read the full article on Seeking Alpha
Articolo di analisi • Jan 08

Is Now The Time To Look At Buying IMAX Corporation (NYSE:IMAX)?

While IMAX Corporation ( NYSE:IMAX ) might not have the largest market cap around , it led the NYSE gainers with a...
Seeking Alpha • Dec 24

IMAX Corporation: Overseas Growth Opportunities

Summary IMAX Corporation's stock has surged 60% since its June lows, but there has been a notable uptick in insider selling in December. IMAX Corporation has considerable long-term growth opportunities and should benefit from an expected well-received movie slate in 2025. An analysis of IMAX Corporation follows in the paragraphs below. Read the full article on Seeking Alpha
Articolo di analisi • Dec 10

IMAX (NYSE:IMAX) Has Some Difficulty Using Its Capital Effectively

When it comes to investing, there are some useful financial metrics that can warn us when a business is potentially in...
Articolo di analisi • Nov 23

IMAX Corporation (NYSE:IMAX) Shares Could Be 44% Below Their Intrinsic Value Estimate

Key Insights IMAX's estimated fair value is US$45.02 based on 2 Stage Free Cash Flow to Equity IMAX's US$25.19 share...
Articolo di analisi • Nov 07

After Leaping 26% IMAX Corporation (NYSE:IMAX) Shares Are Not Flying Under The Radar

The IMAX Corporation ( NYSE:IMAX ) share price has done very well over the last month, posting an excellent gain of...
Articolo di analisi • Oct 31

Here's Why IMAX (NYSE:IMAX) Can Manage Its Debt Responsibly

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
Articolo di analisi • Oct 13

If EPS Growth Is Important To You, IMAX (NYSE:IMAX) Presents An Opportunity

Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...

Previsioni di crescita degli utili e dei ricavi

NYSE:IMAX - Stime future degli analisti e dati finanziari passati (USD Millions )
DataRicaviUtiliFlusso di cassa liberoLiquidità dell'operazioneAvg. Numero di analisti
12/31/2028501951511828
12/31/20274819613017411
12/31/20264618210914411
6/30/202641641100133N/A
3/31/20264053790124N/A
12/31/20254103585127N/A
9/30/20253784064109N/A
6/30/2025362332977N/A
3/31/2025360254089N/A
12/31/2024352263071N/A
9/30/2024346231963N/A
6/30/2024358211757N/A
3/31/202436726-926N/A
12/31/2023375252659N/A
9/30/2023387254371N/A
6/30/202335242148N/A
3/31/2023328-71142N/A
12/31/2022301-23-1517N/A
9/30/2022311-15-426N/A
6/30/2022299-15-718N/A
3/31/2022276-21-713N/A
12/31/2021255-22-126N/A
9/30/2021202-54-25-12N/A
6/30/2021183-93-29-19N/A
3/31/2021141-109-50-40N/A
12/31/2020137-144-32-23N/A
9/30/2020205-104-28-8N/A
6/30/2020254-48-821N/A
3/31/2020350-11N/A97N/A
12/31/201939647N/A90N/A
9/30/201938030N/A109N/A
6/30/201937626N/A112N/A
3/31/201937023N/A94N/A
12/31/201837423N/A110N/A
9/30/201839126N/A90N/A
6/30/201840820N/A95N/A
3/31/201839711N/A101N/A
12/31/20173812N/A85N/A
9/30/20173626N/A96N/A
6/30/201734910N/A79N/A
3/31/201735318N/A72N/A
12/31/201637629N/A78N/A
9/30/201638942N/A87N/A
6/30/201638848N/A102N/A
3/31/201640466N/A83N/A
12/31/201537455N/A84N/A
9/30/201535753N/A57N/A

Previsioni di crescita futura degli analisti

Guadagni vs tasso di risparmio: La crescita prevista degli utili di IMAX ( 21.6% all'anno) è superiore al tasso di risparmio ( 3.7% ).

Guadagni vs Mercato: Si prevede che gli utili di IMAX ( 21.6% all'anno) cresceranno più rapidamente del mercato US ( 17.4% all'anno).

Guadagni ad alta crescita: Si prevede che gli utili di IMAX cresceranno in modo significativo nei prossimi 3 anni.

Ricavi vs Mercato: Si prevede che il fatturato di IMAX ( 6.3% all'anno) crescerà più lentamente rispetto al mercato US ( 13.6% all'anno).

Ricavi ad alta crescita: Si prevede che il fatturato di IMAX ( 6.3% all'anno) crescerà più lentamente di 20% all'anno.

Previsioni di crescita dell'utile per azione

Rendimento futuro del capitale proprio

ROE futuro: Si prevede che il Return on Equity di IMAX sarà basso tra 3 anni ( 16.9 %).

Scoprire le aziende in crescita

7D

1Y

7D

1Y

7D

1Y

Analisi aziendale e situazione dei dati finanziari

DatiUltimo aggiornamento (ora UTC)
Analisi dell'azienda2026/09/21 19:08
Prezzo dell'azione a fine giornata2026/09/18 00:00
Utili2026/06/30
Utili annuali2025/12/31

Fonti dei dati

I dati utilizzati nella nostra analisi aziendale provengono da S&P Global Market Intelligence LLC. I seguenti dati sono utilizzati nel nostro modello di analisi per generare questo report. I dati sono normalizzati, il che può comportare un ritardo nella disponibilità della fonte.

PacchettoDatiTempisticaEsempio Fonte USA *
Dati finanziari della società10 anni
  • Conto economico
  • Rendiconto finanziario
  • Bilancio
Stime di consenso degli analisti+3 anni
  • Previsioni finanziarie
  • Obiettivi di prezzo degli analisti
Prezzi di mercato30 anni
  • Prezzi delle azioni
  • Dividendi, scissioni e azioni
Proprietà10 anni
  • Top azionisti
  • Insider trading
Gestione10 anni
  • Team di leadership
  • Consiglio di amministrazione
Sviluppi principali10 anni
  • Annunci aziendali

* Esempio per i titoli statunitensi, per i titoli non statunitensi si utilizzano forme e fonti normative equivalenti.

Se non specificato, tutti i dati finanziari si basano su un periodo annuale ma vengono aggiornati trimestralmente. Si tratta dei cosiddetti dati TTM (Trailing Twelve Month) o LTM (Last Twelve Month). Per saperne di più.

Modello di analisi e Snowflake

I dettagli del modello di analisi utilizzato per generare questo report sono disponibili sulla nostra pagina GitHub; abbiamo anche delle guide su come utilizzare i nostri report e dei tutorial su YouTube.

Scoprite il che ha progettato e realizzato il modello di analisi Simply Wall St.

Metriche di settore e industriali

Le nostre metriche di settore e di sezione sono calcolate ogni 6 ore da Simply Wall St; i dettagli del nostro processo sono disponibili su Github.

Fonti analitiche

IMAX Corporation è coperta da 20 analisti. 11 di questi analisti ha fornito le stime di fatturato o di utile utilizzate come input per il nostro report. Le stime degli analisti vengono aggiornate nel corso della giornata.

AnalistaIstituzione
Marla BackerAscendiant Capital Markets LLC
David McFadgenATB Cormark Historical (Cormark Securities)
Patrick ShollBarrington Research Associates, Inc.